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Evidence for the functional involvement of T  cell differentiation antigens inT 
cell recognition and/or activation has been provided by various studies in which 
antibodies to certain of these antigens have been shown to inhibit antigen-specific 
cytotoxicity (1-16),  proliferation  (17-19),  and  release of lymphokines (I 6,  20, 
21).  This  phenomenon  has been  most extensively documented by studies that 
have utilized antibodies directed against the T8 molecule (22) (Lyt-2 in mouse), 
the T4 molecule (22) (L3T4 in mouse [23]), and the T3 molecule (22). To date, 
the available data suggest that the T3, T4, and T8 molecules are involved in T 
cell recognition  or activation and are not involved in the lytic process.  Models 
have been proposed in which the T4 and T8 molecules bind to nonpolymorphic 
structures  on class II and class I  MHC antigens  (10,  16,  24), respectively, and 
that  the  T3  molecule  is  intimately  associated  with  the  T  cell  antigen-specific 
receptor (24). 
Studies in mice have shown variation  in the susceptibility of different T  cell 
populations (clones and lines) to the inhibitory effect of anti-Lyt-2 antibodies (6, 
25). Our previous studies have documented variability in the susceptibility of SB- 
specific  cytolytic  T  lymphocyte  (CTL) 1 populations  to  inhibition  by anti-T4 
antibodies (10). These observations have given rise to the hypothesis that the T4 
molecule may play a  role in  facilitating  interactions  of low affinity clones but 
may be irrelevant  to the recognition process of high affinity clones (6,  10, 25). 
The present'study explores the relationship  between the susceptibility of CTL 
clones to inhibition  by anti-T  cell antibodies and the tightness with which they 
bind  targets  as  estimated  by a  previously published  assay of CTL-target  cell 
conjugate  dissociation.  In  addition,  this  dissociation  assay partitions  the  lytic 
process into binding vs. lethal hit phases and provides a more direct demonstra- 
tion of the role of the T4 molecule in target cell binding. 
Correspondence should be addressed to Dr. W. E. Biddison, NIH, Bldg. 10-Rm. 5B 16, Bethesda, 
MD 20205. 
~Abbreviations used in  this paper: CTL, cytotoxic T  lymphocyte; EGTA, ethyleneglycol-bis-(B- 
amino-ethyl ether N,N'-tetra-acetic acid); FMF, flow microfluorometry; MHC, major histocompati- 
bility complex; MLC, mixed lymphocyte culture; PBL, peripheral blood lymphocytes; PHA-sup, 
supernatant from PHA-stimulated PBL; TCGF, T cell growth factor. 
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Materials and Methods 
Human Blood Reagents.  Peripheral blood mononuclear leukocytes (PBL) and plasma 
were obtained by batch leukapheresis of normal adult volunteers (26). PBL were separated 
by flotation on FicolI-Hypaque and were cryopreserved as described (26).  Plasma from 5- 
10 such male donors was pooled, frozen in aliquots at -20°C, and used as the normal 
human plasma pool. H LA serotyping of cells was kindly performed by Dr. R.J. Duquesnoy, 
Blood Center of Southeastern Wisconsin,  Milwaukee, WI. SB typing was performed by 
primed lymphocyte typing as previously described (27-29). The HLA phenotypes of the 
donors used in this study are given in Table I. 
Immunochemical Reagents.  Purified monoclonal antibodies were prepared from ascites 
as described (22).  The monoclonai antibodies used in these studies are OKT4 (IgG2b) 
(22), OKT4A (IgG2a) (30), OKT4B (IgM) (30), OKTSA (IgG2) (31), and OKT3 (IgG2a) 
(22).  An  additional  antibody to the  T4  molecule,  OKT4F  (IgG1), was produced  and 
characterized as previously described for OKT4, 4A, and 4B (22, 30). Protein A-Sepharose 
(Pharmacia Fine Chemicals, Piscataway, NJ)-purified anti-Tac (IgG2a) (32,  33) was the 
generous gift of Dr. T. Waldmann (National Cancer Institute, Bethesda, MD). Anti-Tac 
binds to the cell surface receptor for T  cell growth factor (TCGF) (32, 33). 
Generation and Assay of Cloned SB-Specific CTL.  Bulk CTL effector cells were generated 
in primary and secondary mixed lymphocyte culture (MLC) as previously described (27- 
29). Responder and stimulator cells were matched for HLA-A, -B, -C, -D, -DR, MB, and 
MT but mismatched for SB; responder-stimulator combinations were identical to those 
used to generate  the  standard  primed  lymphocyte typing reagents that  define  the  SB 
specificities (27-29).  Secondary MLC cells were stimulated with specific stimulators for 
2-3 d  then cloned at 3 and 0.3  cells/well in flat-bottom 96-well plates (Costar #3596; 
Costar, Data Packaging, Cambridge, MA) in complete medium consisting of RPMI 1640 
with  glutamine  (Grand  Island  Biological  Co.,  Grand  Island,  NY  and  Biofluids,  Inc., 
Rockville, M D) supplemented with penicillin (100 U/ml), streptomycin (100 #g/ml), and 
10% normal human plasma. Wells were supplemented with 40% supernatant from PHA- 
5  stimulated PBL (PHA-sup, see below) and 10  6000R PBL feeder cells that expressed the 
relevant SB antigen.  10-14 d later wells with visible cell growth were assayed for cytolytic 
activity. Cytolytic clones were expanded repeatedly as follows: ~ 105 cells were transferred 
to a 2-cm  2 well (Linbro #76-033-05;  Linbro Chemical Co., Hamden, CT) containing 1 × 
106 6000R stimulator PBL in 1.5 ml complete medium. 24 h later each well received 0.4 
mi PHA-sup. 5-6 d later rapidly growing clones were reexpanded once more or cryopre- 
served (26) before further expansion. All T  cell clones used in the present study were 
derived from initial cloning at 0.3 ceils/well or were recloned at that concentration. 
The standard  5~Cr release cytotoxicity assay was performed as previously described 
(26).  Effector cells were assayed 5 d after stimulation with PBL stimulators and 18-24 h 
TABLE  I 
HLA Phenotypes of Donors 
Donor  HLA-A  -B  -C  -DR  -SB  MB  MT 
B17  1,2  7,8  7  2,4  2,4  1,3  1,3 
C5  1,3  8  --  3,5  2,4  2,3  2 
F2  1,2  7,8  --  2,4  4,5  1,3  1,3 
FB6  25,31  15,40  3  4,4  4  3  3 
FBll  25,31  15,40  3  4,4  1  3  3 
H9  1,2  7,8  7  2,3  1,2  1,2  1,2 
K4  1,2  7,8  7  1,3  1  1,2  1,2 
M14  1,2  7,8  7  2,3  3,4  1,2  1,2 
M16  1,3  8,14  --  2,3  1,2  1,2  1,2 
PM1  1,2  7,8  7  2,3  2,3  1,2  1,2 
Sll  1,2  7,8  7  2,3  2,5  1,2  1,2 
W7  1,2  7,8  7  2,3  1,4  1,2  1,2 BIDDISON  ET  AL.  785 
after  boosting  with  fresh  stimulators.  Target  cells  were  lymphoblastoid  B  cell  lines 
transformed with Epstein-Barr virus (27).  In antibody-blocking assays, effector cells were 
preincubated with antibodies  15-20 min at 37  C before addition of 51Cr-labeled  target 
cells;  incubation  times for these assays ranged from  1.5-4 h  and were chosen so as to 
achieve unblocked lyses in an optimum range (20-50% specific lysis). 
Generation of PHA-sup.  Growth  media  for  T  cell  clones  was  generated  by  PHA- 
stimulation of PBL from selected donors. 80 x  10  6 PBL, 12 X 106 lymphoblastoid B cells 
from donor H9 (H9B), 0.8 ml PHA M form (Gibco), and 0.8 ml normal human plasma 
plus RPMI 1640 with penicillin and streptomycin in a final volume of 80 ml were cultured 
in an upright plastic flask (Falcon #3023;  Falcon Labware, Oxnard, CA) for 48 h. The 
supernatant was harvested, centrifuged to remove cells, filtered through a 0.45-#m filter 
(Nalge Co.,  Rochester,  NY),  and frozen in  aliquots at  -70°C.  The growth-promoting 
activity of the supernatant was assayed by its ability to promote growth of cloned CTL. 
Assay  for Dissociation of Functional CTL-Target Cell Conjugates.  This assay was performed 
essentially as described by Balk and Mescher (34).  All  manipulations were performed in 
RHS medium or in modifications of this medium. RHS medium consists of RPMI  1640 
without NaHCO3 (Gibco) supplemented with salts to yield 127 mM NaC1, 1.8 mM MgCl2, 
and  1.3  mM  CaCI2,  10  mM  Hepes,  pH  7.2-7.4,  100  U/ml  penicillin,  100  #g/ml 
streptomycin, and  5%  heat-inactivated  fetal  calf serum.  RHS-EGTA medium  is  RHS 
medium  with  5  mM  EGTA  (ethyleneglycol-bis-(B-amino-ethyl ether) N,N'-tetra-acetic 
acid, a Ca  ++ chelator) (Sigma Chemical Co., St. Louis, MO). RHS-Dextra medium is RHS 
medium with 10% wt/vol dextran T-500 (Pharmacia Fine Chemicals). 
Cloned CTL and 51Cr-labeled target cells were washed once in RHS-EGTA medium 
and resuspended at 10 x  106/ml (CTL) or 1 X 106/ml (targets) in RHS-EGTA. Step 1: 
conjugate formation. Typically, 2 ml of CTL and 1 ml of targets were placed in a round- 
bottom  12  x  75 mm tube (Falcon #2058) and centrifuged for 5 min at 250 g at 23°C. 
Step 2: conjugate dissociation.  1,700  #1 of supernatant was removed and the cell pellet 
gently resuspended in the remaining medium. 0.1-ml aliquots of CTL-target conjugates 
were then transferred to 16 x  125 mm tubes (Falcon #3033) containing 0.2 ml medium 
RHS-EGTA alone or in medium containing various concentrations of unlabeled compet- 
itor B cells. These tubes were then secured upright in a test tube rack that was fixed on 
an orbital shaker (33-cm platform, Arthur H. Thomas, Philadelphia, PA) and shaken at a 
setting of 6-6.5 to keep cells in suspension. Step 3: conjugate measurement. At varying 
times tubes were removed from the shaker and duplicate 0.1-ml aliquots per sample were 
transferred to each of two  12 x  75 mm tubes with caps (Falcon #2058) containing 2 ml 
RHS-dextran. The tubes were vortexed and incubated upright in a waterbath for 4 h at 
37°C to permit lysis of bound targets. 2 ml of cold phosphate-buffered saline were then 
added to each tube, the tubes were vortexed, centrifuged at 1,600 g for 10 rain, and 3 
ml of supernatant (¾ of total) removed for measurement of 51Cr release. Both supernatant 
and pellet for each sample were counted and the percent total release calculated by the 
formula: [supernatant cpm X 1.33/(supernatant cpm +  pellet cpm)] X  100. The specific 
release was calculated as (% total release -  % spontaneous release)/(95% -  % spontaneous 
release) (26). 
Indirect Immunofluorescence and Flow Microfluorometry (FMF).  Cell surface antigens were 
analyzed on CTL clones by indirect immunofluorescence and FMF using a FACS IV cell 
sorter (B-D FACS Systems, Becton, Dickinson and Co., Sunnyvale, CA) with logarithmic 
amplification and data collected in  256  channels.  For FMF analysis, CTL clones were 
expanded for 5 d in the presence of specific 6000 R PBL stimulator cells plus 6.7% lectin- 
free TCGF derived from the  MLA  144  gibbon T  cell line (35)  (a kind gift of Dr.  F. 
Ruscetti, Frederick Cancer Research Center, Frederick, MD). Cells were incubated with 
saturating concentrations of antibodies (1:1,000 dilution of ascites for antibodies OKT3, 
OKT4, and OKT8 or  10  #g/ml of anti-Tac) as previously described (36), and stained 
with a fluorescein-conjugated F(ab')~ preparation of goat anti-mouse IgG (heavy and light 
chain  specific,  N.L.  Cappel  Laboratories,  Cochranville,  PA).  The  mean  fluorescence 
intensity of cells in a positive peak was calculated as follows:, (channel no. x  no. of cells 
in channel)/total no. of cells in peak. The percentage of positive cells was determined as 786  INVOLVEMENT  OF  THE  T4  MOLECULE  IN  T  CELL-TARGET  BINDING 
the percentage  of cells to the right of the overlap of the negative control curve with the 
curve obtained with antibody. 
Results 
Characterization of SB-Spec~c CTL  Clones.  The seven SB-specific CTL clones 
(Table II) utilized in the present study were derived by limiting dilution culture 
at 0.3 cells per well from three primed lymphocyte populations identical to those 
used  to  originally  define  the  SB  antigens.  The  specificity  of the  clones  was 
confirmed by cytotoxicity testing on panels of B cell lines (Table II). For example, 
the two clones derived from an  SBl-specific bulk population (1.1,  5.5)  killed 
only the  two SBl-positive targets  among the five B  cell  lines matched for all 
known HLA antigens except SB. 
All of the clones were analyzed by FMF for the presence of cell surface T3, 
T4,  T8,  and  Tac  antigens  by  indirect  immunofluorescence with  the  OKT3, 
OKT4,  OKT8A, and anti-Tac antibodies (Table  III). All fluorescence profiles 
appeared unimodal, and gave no indication of discrete subpopulations of cells 
TABLE  II 
SB Specificity of CTL Clones 
Derived from donor combina-  Expected  Percent specific lysis of target cells* 
Clone  tion  specificity  H9B  K4B  W7B  M14B  PM1B  SllB 
1.1  FB6 anti-FB11  SB1  17  14  23  -2  0  0 
5.5  FB6 anti-FB11  SB1  27  38  32  1  0  -1 
SB specificities of target:  1,2  1  1,4  3,4  2,3  2,5 
DR specificities of target:  2,3  1,3  2,3  2,3  2,3  2,3 
C5B  H9B  FB6B  FBllB  M14B 
8.1  W7 anti-H9  SB2  24  45  -2  2  0 
8.2  F2 anti-B17  SB2  15  17  -2  3  0 
8.4  F2 anti-B17  SB2  27  49  -1  1  0 
8.6  F2 anti-Bl 7  SB2  9  19  -1  0  -1 
8.8  F2 anti-B17  SB2  67  79  5  -1  -2 
SB specificities of target:  2,4  1,2  4  1  3,4 
DR specificities of target:  3,5  2,3  4,4  4,4  2,3 
* All CTL clones were assayed at effector/target (E:T) of 10:1 or 20:1. 
TABLE  III 
Cell Surface Phenotype of CTL Clones 
Clone 
Percentage of cells binding above background: 
OKT3  OKT4  OKT8A  Anti-Tac 
1.1  96 (100)*  96 (100)*  0  74 
5.5  89 (88)  93 (95)  13  86 
8.1  89 (99)  89 (96)  7  49 
8.2  93 (94)  94 (94)  5  67 
8.4  92 (96)  91  (92)  1  49 
8.6  94 (108)  94 (113)  0  40 
8.8  96 (116)  96 (109)  0  73 
* Number in parentheses  are the mean  fluorescence intensity values of 
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within the clonal populations (data not shown). All clones were clearly T3 +, T4  +, 
T8-,  except that  clone  5.5  was  highly autofluorescent and  gave background 
staining of 5-15%  positive with all  antibodies  tested,  including OKT8A.  No 
significant differences were noted between the clones in the level of expression 
of the T3  or T4  molecules as measured by mean fluorescence intensity. The 
surface expression  of the  Tac  antigen  was  variable  among  the  clones.  The 
majority of the cells in  a  clonal population  were Tac  +,  but  there was a  wide 
spectrum of very dull and very bright cells (data not sbown). 
Inhibition  of CTL Activity  by Monoclonal  Antibodies.  The panel  of SB-specific 
CTL clones was assayed for susceptibility to inhibition of CTL activity by the 
monoclonal antibodies OKT3, OKT4A, OKT4F, and anti-Tac (Fig. 1). Cytotox- 
icity was  assayed on  M16B  targets  that  express  both  SB1  and  SB2  antigens. 
Marked  differences in  susceptibility  to  inhibition  were  observed  among  the 
clones.  Although  both  SBl-specific  clones  (1.1  and  5.5)  were  inhibited  by 
OKT4A and OKT3, 1.1 was completely inhibited by a concentration of OKT4A 
(1  pg/ml) that resulted in little blocking activity on clone 5.5.  This difference 
for inhibition by OKT4A was paralleled by a similar difference for inhibition by 
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FIGURE  1.  SB-specific CTL clones differ in their susceptibility to inhibition by anti-T3 and 
anti-T4 antibodies. SB-specific CTL clones (50 pl) were preincubated for 20 min with 50/A of 
the indicated concentrations of monoclonal antibodies anti-Tac (T), OKT3 (O), OKT4A (O), 
OKT4F (A), or medium alone (--No Ab). 51Cr-labeled M16B target cells (50 p]) were then 
added and lysis was measured 2-4 h later. E:T =  10:1 or 20:1. 788  INVOLVEMENT OF THE  T4  MOLECULE IN  T  CELL-TARGET BINDING 
OKT3. Antibody OKT4F, which binds to an epitope on the T4 molecule distinct 
from OKT4A, had marginal  blocking activity on any of the clones, as did anti- 
Tac.  The  SB2-specific  clones  also  differed  widely  in  their  susceptibility  to 
blocking: clone 8.4 was completely refractory to inhibition  by any of the anti- 
bodies at concentrations as high as 25 ~g/ml.  Clones 8.6 and 8.8 were strongly 
inhibited by OKT4A at 5-25 #g/ml,  whereas these concentrations of OKT4A 
produced little inhibition of 8.1 or 8.2. 
Assay  for Tightness of Binding of CTL to Targets.  The differences in the suscep- 
tibility of T4  ÷ SB-specific CTL to inhibition  by anti-T4 and anti-T3  antibodies 
could  be  due  to  differences  in  the  affinity  of the  CTL  for  targets.  Classical 
measurements of affinity performed on molecules in solution cannot be used to 
assess  the  affinity  of  interaction  between  cells.  As  an  alternative,  we  have 
estimated how tightly the CTL are bound to targets by determining the dissocia- 
tion  of CTL-target  cell  conjugates in  the presence  of an  excess of unlabeled 
competitor cells identical  to the  targets.  The  procedure  for making  this  mea- 
surement is essentially as described by Balk and Mescher (34). The assay can be 
viewed as  three  distinct  steps:  (a)  formation  of conjugates;  (b) dissociation  of 
conjugates; and (c) enumeration of remaining conjugates. The first two steps are 
performed in Ca++-free medium to allow normal binding but to prevent delivery 
of the  lethal  hit.  Conjugate  formation  is  optimized  by pelleting  effectors and 
labeled targets.  The dissociation phase is in suspension with continuous mixing 
in the presence of graded  doses of competitor cells identical  to the target  but 
unlabeled. The number of labeled targets remaining in conjugates after dissocia- 
tion  (and/or exchange  with  competitor cells [34]) is estimated by transferring 
the cells to Ca÷+-containing medium at 37°C to allow delivery of the lethal hit 
in existing conjugates, but in a semi-solid medium to prevent formation of new 
conjugates. 
The ability of cold targets to reverse functional CTL-target cell conjugates is 
illustrated by the results in Fig.  2. Clone 8.8 cells were mixed with 5~Cr-labeled 
M 16B targets, centrifuged, and diluted either with medium alone or unlabeled 
M 16B cells. Aliquots of these mixtures were either  transferred  immediately to 
the dextran  medium to measure the control level of lysis by functional  CTL- 
target cell conjugates (time 0), or they were cultured in suspension for 1, 2, or 4 
h before transfer to dextran.  Culture in suspension with medium alone did not 
significantly  change  the  level  of 5~Cr release,  indicating  that  CTL-target  cell 
conjugates could not readily dissociate in the absence of competing cells. Addition 
of cold M 16B cells induced complete inhibition of 51Cr release by 2 h of culture, 
indicating  that  functional  CTL-51Cr-labeled  target  cell  conjugates  could  be 
completely dissociated by competitor cells. Addition  of competitor cells in the 
dextran (lytic) phase had no effect, since there is no significant difference between 
the lysis obtained at time 0 with or without added M 16B cells. These results are 
very similar to those originally described by Balk and  Mescher (34).  All subse- 
quent  assays were performed  by incubating  the  formed conjugates for  3  h  in 
medium or medium with unlabeled competitor cells, at which point dissociation 
is readily observed. 
Studies were then performed to analyze the ability of graded doses of compet- 
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FIGURE 2.  Kinetics  of reversal  of functional  CTL  conjugates.  Conjugates  were  formed 
between clone 8.8 and M16B 5~Cr-labeled.targets by centrifugation. Conjugates were then 
diluted in either media alone (e) or media containing unlabeled M16B cells at 20 x  10e/ml 
(O) and shaken for various times at 23°C.  Aliquots were then transferred to RHS-dextran 
medium for 4 h at 37°C to measure 51Cr release from remaining conjugates. 
seven clones. A typical study comparing two clones (8.1, 8.8) is shown in Fig. 3. 
SB2 + cold targets M16B are able to induce dissociation of 5]Cr-labeled M16B- 
8.8  conjugates  (measured as  a  decrease in  subsequent  5~Cr release),  but  not 
M 16B-8.1  conjugates. The number of cold M 16B cells required to inhibit 50% 
of the control  lytic activity of clone 8.1  is  at  least  10-fold greater than  that 
required to inhibit the same amount of lytic activity of clone 8.8. The competition 
is specific, as originally described (34), since little or no dissociation of functional 
conjugates is induced by competing cells autologous to the responder (which lack 
the SB2 antigen). 
Comparison of CTL  Clones for  Tightness of Binding  Targets and Susceptibility to 
Inhibition  by Anti-T4  and Anti-T3 Antibodies.  To determine whether there is a 
correlation between susceptibility to inhibition by OKT3/OKT4A and tightness 
of cell interaction (estimated by the dissociation studies), the titration data in 
each system were reduced to a single value representing the number of cells or 
quantity of antibody required to reduce cytotoxic activity to 50% of the control 
value. The values were then tabulated and compared (Table IV). The results of 
experiment  1  demonstrate  that  clones  8.1  and  8.8  differ as  follows:  (a)  8.1 
requires greater than 10-fold more competitor cells to induce conjugate dissocia- 
tion than does 8.8; and (b) 8.1 requires at least 50-fold more anti-T4 and 10-fold 
more anti-T3 antibody to inhibit cytolytic activity than does 8.8.  Similar com- 
parisons  with  different clones are shown in  experiments 2-4.  In each paired 
comparison, the clone that requires the most competitor cells to induce conjugate 
dissociation requires the most anti-T4 and anti-T3 antibody to inhibit cytotox- 
icity. A comparison of two clones that require almost identical quantities of anti- 
T3 and anti-T4 antibodies to inhibit cytotoxicity (clones 1.1  and 8.8 in experi- 790  INVOLVEMENT  OF  THE  T4  MOLECULE  IN  T  CELL-TARGET  BINDING 
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FIGURE 3.  Comparison  of clones 8.8 and 8.1 for tightness of binding to specific target cells. 
Conjugates were formed between clones 8.8 or 8.1 and 5~Cr-labeled M  16B cells by centrifuga- 
tion. Conjugates were then diluted in medium alone (--control),  various concentrations of 
unlabeled SB2-negative F2B cells (e), or unlabeled SB2-positive M16B cells (O), and shaken 
for 3 h at 23°C. Aliquots were then transferred to RHS-dextran medium for 4 h at 37°C to 
measure 5]Cr release from remaining conjugates. 
ment  5)  demonstrates  that  they  require  virtually  identical  concentrations  of 
competitor cells for dissociation in  the conjugate reversal  assay. These results 
indicate that  within this  panel  of SB-specific  CTL  clones,  there  is an  inverse 
correlation between tightness of target cell binding and susceptibility to inhibition 
by anti-T4 and anti-T3 antibodies. 
Dissociation of Functional CTL-Target Cell Conjugates by Anti-T4 Antibodies.  If 
the  T4  molecule  is  involved functionally in  target  cell  binding,  then anti-T4 
antibodies might induce dissociation of conjugates.  To address this possibility 
experimentally, the conjugate dissociation assay was performed as described in 
Fig. 3 and Table IV with the following modification: anti-T4 and control anti- 
Tac antibodies were substituted for unlabeled competitor cells in the dissociation 
phase.  Results of such an assay with five clones are given in Table V.  OKT4A 
and OKT4B, but not anti-Tac, appeared to partially induce dissociation of ~]Cr- 
labeled targets from four clones, although this was not very striking for clone 
8.1.  To  assure  that  the  blocking  observed  was  due  to  its  effect during  the 
dissociation (step  2) rather than the lethal hit stage (step 3),  the controls were 
performed with addition of an equivalent amount of antibody at step 3 (Table 
V, right-hand column). Inhibition by anti-T4 antibodies at step 3 was negligible. 
Clone 8.4 appears to be the "highest affinity" clone in the panel, since it is the 
most  resistant  to  antibody-mediated  blocking  of cytotoxicity  and  conjugate 
dissociation  induced  by  competitor  cells.  Clone  8.4  was  also  unique  in  that 
OKT4A could not induce dissociation of 8.4-M16B  conjugates when the assay BIDDISON ET AL.  791 
TABLE  IV 
Comparison of Number of Unlabeled Specific Competitor Cells Required 
to Reverse CTL-Target Conjugates with Amount of OKT4A and OKT3 
Required to Inhibit Cytotoxicity 
Expt.  Clone 
no. 
Amount required to reduce cytotoxicity by 
50%:* 
M 16B competitor  OKT4A  OKT3 
cells x  lO~/ml *  tzg/ml*  ug/ml* 
1  8.1  >20  >25  5.0 
8.8  2.6  0.5  0.5 
2  8.2  16  >25  5.0 
8.6  1.3  0.6  0.6 
3  1.1  6.7  0.6  0.6 
5.5  >2O  2.0  18 
4  8.4  >20  >25  >25 
8.6  6.7  0.6  0.6 
5  1.1  5.4  0.6  0.6 
8.8  4.2  0.5  0.5 
* Each cloned CTL was reacted with 5ZCr-labeled M16B targets and CTL- 
target conjugates were reversed by dilution and incubation with graded 
numbers of unlabeled MI6B as in Fig. 4. The number of unlabeled 
M16B competitor cells required  to reduce  cytotoxicity by 50% (i.e., 
percent specific lysis in the absence of competitor cells/2)  was then 
interpolated from the titration curve. 
* Values are  the amount  (in  #g/ml) of antibody required  to  reduce 
cytotoxicity by 50% (relative to lysis in the absence of antibody). Values 
are interpolated from the antibody titration curves in Fig. 1. 
was performed under standard conditions (23°C) (Table V). As one approach to 
determine whether anti-T4 antibodies could induce conjugate dissociation under 
different experimental conditions, the temperature of the conjugate formation 
and  dissociation  steps  was  lowered  to  4°C.  The  overall  level  of  conjugate 
formation was lower at 4°C, as revealed by the lower lysis in medium only (25% 
vs. 60%), but at 4°C marked dissociation was induced by OKT4A (Table V). 
Discussion 
Previous studies have demonstrated  that antibodies against  the T4 molecule 
can inhibit antigen-specific functions of T4  + cells (10,  11,  16-19).  It has been 
hypothesized that this antibody-mediated inhibition results from the disruption 
of binding of T  cells to targets, perhaps by interference with the T4 molecule 
binding to a  nonpolymorphic epitope on class II  MHC molecules (10,  16,  24). 
However, considerable  heterogeneity among  SB-specific CTL populations has 
been  observed  in  their  susceptibility  to  inhibition  by anti-T4  antibodies  (10). 
SB2-specific bulk  culture-derived  CTL  were  much  more resistant  to anti-T4 
inhibition than were analogous CTL populations specific for SB1,3, or 4 (10). It 
was proposed that these observed differences might reflect differences between 
SB-specific T  cell clones  in  their  affinity for antigen  (10).  The  present  study 
demonstrates that: (a) there is considerable clonal heterogeneity in the ability of 
SB-specific CTL clones to be inhibited by anti-T4 as well as anti-T3 antibodies; 
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TABLE  V 
Anti-T4 Antibodies Can Induce Partial Dissociation of Functional 
CTL-Target Cell Conjugates 
Clone  Antibody 
Phase of antibody addition* 
Conjugate dissociation  Lysis 
(step #2)  (step #3) 
1.1 
4°C  23°C 
None  41'  41 ¢ 
Anti-Tac  40  40 
OKT4A  27  40 
OKT4B  25  44 
5.5  None  42  42 
Anti-Tac  43  40 
OKT4A  21  36 
8.1  None  58  58 
Anti-Tac  58  60 
OKT4A  46  54 
8.2  None  55  55 
Anti-Tac  49  53 
OKT4A  33  46 
8.4  None  25  60  60 
Anti-Tac  19  56  56 
OKT4A  9  61  61 
* MI6B 51Cr-labeled targets were mixed with CTL clones, centrifuged at 
4°C or 23°C, and diluted in either RHS-EGTA medium or antibodies 
diluted in the same medium to 25 jzg/ml.  During the conjugate disso- 
ciation phase, the mixture of cells with and without antibodies were kept 
in suspension culture for 3 h at 23°C, except  for clone 8.4 which was 
cultured at either 4°C or 23°C. An aliquot  of this mixture was then 
transferred to 2 ml of 10% dextran medium and lysis of bound targets 
was allowed  to  proceed at  37°C  for  4  h.  For  control  of antibody 
inhibition oflysis in the dextran phase of  the assay, an aliquot of  antibody 
equivalent  to that transferred with the conjugate mixture was included 
in the 10% dextran medium. 
* % specific lysis after 4 h in 10% dextran medium. 
to  targets  as  estimated  by  CTL-target  cell  dissociation  in  the  presence  of 
competitor cells;  (c) clones that are  most susceptible  to antibody-mediated  inhi- 
bition are those that bind targets less tightly, and vice versa; and (d) antibody to 
the  T4  molecule  not  only  can  block  killing  but  can  induce  dissociation  of 
preformed CTL-target  cell conjugates. 
Antibodies  that  inhibit  cytolysis could  block  at  any  stage  of the  complex  of 
events in ceil-mediated cytotoxicity. This process can be partitioned  into at least 
two steps:  1) Ca++-independent  binding and conjugate  formation; and  2) Ca ++- 
dependent  delivery  of the  lethal  hit  (37-39).  The  present  study indicates  that 
the T4  molecule participates  in the binding phase,  since anti-T4 antibodies  can 
disrupt  functional  CTL-target  cell conjugates.  This role for T4  molecules may 
be analogous to that  proposed  for the  T8/Leu-2  molecule  in humans  and  the BIDDISON ET AL.  793 
Lyt-2 molecule in mice. Both anti-Leu-2a (14) and anti-Lyt-2 (40) antibodies 
were able to inhibit the binding phase, but not the lytic phase of CTL-mediated 
cytolysis. Results from two different approaches are consistent with a role for T4 
in T  cell activation and/or binding.  First,  anti-L3T4 antibody in mice blocks 
binding of antigen-specific L3T4 + T  cell hybridomas to antigen-pulsed antigen- 
presenting cells (23).  Second, anti-T4 antibodies in man (16-19) and the anti- 
L3T4 antibody in mice (23) block antigen-specific proliferation. 
Marked differences were observed in the SB-specific CTL clones studied in 
their susceptibility to inhibition by anti-T4 antibodies. Similar observations were 
made for the susceptibility of Lyt-2  + CTL  clones to  inhibition  by anti-Lyt-2 
antibodies (6, 25). Such clonal heterogeneity was postulated to reflect differences 
in the affinity of T  cell clones for antigen (6, 10, 25). Perhaps the most suggestive 
evidence for this hypothesis was that the specific reactivity of an anti-Moloney 
sarcoma virus plus  H-2  b CTL  clone was  resistant  to  inhibition  by anti-Lyt-2 
antibody, while the allogeneic cross-reactivity of this same clone on uninfected 
H-2  a targets was inhibited by anti-Lyt-2 antibody (25).  To test tl~is hypothesis 
regarding affinity, we have assessed differences between clones in meir tightness 
of binding  to  targets.  The  assay  chosen  to  quantitate  tightness  of binding 
measured the ability of cold targets to induce dissociation of preformed conju- 
gates. Balk and Mescher (34) used this assay system to demonstrate that target 
cell binding to CTL  was a  reversible process, and that exchange could occur 
between bound and unbound targets (34). Using this assay, we observed marked 
heterogeneity in  the number of unbound competitor cells required to induce 
dissociation of bound  target  cells from individual  CTL  clones. Although the 
binding  events  are  undoubtedly  complex,  we  would  expect  that  differences 
between the affinities of the antigen-specific receptors of the different clones 
would be the most important factor that contributes to differences in the tightness 
with which CTL bind targets. However, other differences, such as cell surface 
density of antigen-specific receptors or density of cell adhesion molecules (see 
below)  or  even  differences in  lateral  mobility of those  molecules could  also 
contribute  to  differences in  the tightness  of target  cell  binding.  To  date  no 
evidence has been reported for a structural polymorphism ofT3 or T4 molecules 
on different T  cell clones, and we have noted no significant differences in the 
density of the T3  or T4  molecules on  the seven clones in  the present study 
(Table III) (such differences in level of expression of L3T4 have been detected 
on mouse CTL clones by cell sorter analysis [23]). 
Collectively the available data suggest that the T4 molecule is one of a number 
of cell adhesion molecules on human T  lymphocytes. The high frequency of T4 
expression on class II MHC-reactive T  cells prompted us and others (10, 16, 24) 
to postulate that the function of the T4 molecule is to bind to a nonpolymorphic 
epitope on class II MHC molecules. Such a binding function could serve to focus 
class II MHC molecules onto the surface ofT cells and also to provide a stabilizing 
function for the interaction of low affinity T  cells with antigen-bearing cells. The 
observation that a "high affinity" clone such as 8.4 can be dissociated from bound 
targets  by anti-T4  antibodies  at  4°C  but  not  at  23°C  indicates  that  the  T4 
molecule is providing a binding function even on high "affinity" clones. In order 
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it  is  necessary  to  artificially  lower  the  apparent  avidity  of the  CTL-target 
interaction by lowering the binding temperature. It remains to be seen whether 
this indication of T4 function in such a  clone will be irrelevant to its function 
under physiologic conditions or whether it accurately reflects the importance of 
T4 molecules to all T4-positive clones. 
What  is  the role of the T3  molecule in  T  cell-mediated cytotoxicity? The 
correlation between the doses  of anti-T3  and anti-T4  antibodies  required to 
inhibit cytotoxicity by clones with differing "affinity" could suggest that T3, like 
T4,  acts at  the binding phase.  However, evidence from two different studies 
indicate that anti-T3  antibody cannot block conjugate formation (14,  15),  or 
reverse  preformed  conjugates  (15),  but  can  inhibit  a  post-adhesion  step  in 
cytolysis (15).  Work in  progress on our clones also indicates that anti-T3  can 
inhibit at the post-adhesion step, which complicates interpretation of the partial 
inhibition  seen with  addition  at  the dissociation step.  Meuer et al.  (41)  have 
demonstrated that the T3 molecule co-modulates with the antigen-specific recep- 
tor and suggested that this molecule is involved in T cell triggering. It is therefore 
possible that the inhibitory effects of anti-T3 antibodies could be due to indirect 
effects on the closely associated antigen-specific receptor (41). Thus, T4 and T3 
may be operative in different T  cell functions. Perhaps inhibition of both cell 
adhesion (anti-T4) and of triggering (anti-T3) may be subject to affinity-depend- 
ent differences between clones. 
At least four different molecules have now been defined on human T  cells 
that are distinct from the antigen-specific receptor and appear to be involved in 
T  cell binding of antigen-bearing cells: T4 on class II-reactive cells (10,  11,  16- 
19), T8 on class I-reactive cells (8,  1 I,  14,  16,  17,  19),  LFA-1 (42), and LFA-2 
(42). The general picture that is emerging from all of these studies is that the 
binding of a target cell or antigen-presenting cell by a T cell involves a collection 
of molecular interactions. It is unclear how interactions of these diverse molecules 
are orchestrated into the finely regulated, highly specific response characteristic 
of T  cell clones. Perhaps there is some complex additivity of their affinities for 
the  target  cell;  perhaps  there  is  some  loose  physical  association  of  several 
molecules into a receptor complex; or perhaps there are intracellular mechanisms 
for coordinating signals that they transduce. Novel approaches will be required 
to elucidate these complex possibilities. 
Summary 
The present study examines the potential role of the T4 molecule in functional 
cell-cell interactions between target cells and human cytotoxic T  lymphocyte 
(CTL) clones that are specific for HLA class II alloantigens encoded by the SB 
locus. There were marked differences (greater than 30-fold) between the seven 
SB-specific clones studied with respect to their susceptibility to inhibition by anti- 
T4  as well as anti-T3  antibodies.  We wished to test the hypothesis that such 
variation among the clones would be due to differences in clonal "affinity" for 
antigen. To quantitate differences among the CTL clones in the tightness with 
which they bind target cells, the clones were analyzed using a previously published 
assay of susceptibility of CTL-target cell conjugates to dissociation in the pres- 
ence of unlabeled targets. The results revealed that the clones that were most BIDDISON ET AL.  795 
susceptible  to  inhibition  by anti-T4  and  anti-T3  were  the  weakest  target  cell 
binders, and vice versa. Anti-T4 antibody could partially induce dissociation of 
functional CTL-target cell conjugates in the absence of any added cold targets. 
For the "highest affinity" clone such anti-T4 antibody-induced dissociation could 
be observed at 4°C but not 23°C. These results indicate that the T4 molecule is 
functionally involved in target cell binding by CTL, and raise the possibility that 
although  it is  easiest to demonstrate  the function of the  T4  molecule in  "low 
affinity" clones, that function may also be operative in the "high affinity" clones. 
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